Tuesday, October 22, 2019

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (CSE: $PLTH.C) (CSE: $TER.C) (CSE: $TGIF.C) (TSX: $ACB.TO) (NYSE: $ACB) (OTC: $OWPC)

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (CSE: $PLTH.C) (CSE: $TER.C) (CSE: $TGIF.C) (TSX: $ACB.TO) (NYSE: $ACB) (OTC: $OWPC)



Delta, Kelowna, BC –October 22, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.




Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts

In today’s podcast we look at a few of today’s early announcements.


Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNHFannounced today that it has launched a new beverage brand, Elysium, a refreshing THC-infused line of low-calorie flavored sparkling water.
"Elysium marks our first step into the exciting THC beverage space. We've created and perfected a sparkling water beverage based on both customer demand and market trends. This low-calorie refreshing drink with zero added sugar was designed to be a fast-acting alternative without the guilt, the perfect micro-dosing beverage," said Bob Groesbeck Co-CEO of Planet 13. "Our expanded production facility will enable us to increase production of our top selling TRENDI line and begin production of Elysium and our highly anticipated edibles lines Dreamland Chocolates and HaHa Gummies. Customers will be able to watch these brands being manufactured behind glass. Increased sales of inhouse brands will drive margin expansion and ultimately shareholder value."
Elysium is a line of flavored sparkling beverages available in five flavours: Valencia Orange, Persian Lime, Eureka Lemon, Wild Berry, and Ruby Red Grapefruit. All flavors are low calorie, zero sugar using all-natural fruit flavourings and designed for an uplifting high.
TerrAscend Corp. (CSE: TER) (OTCQX: TRSSFtoday announced that it has received an amendment to its license from Health Canada to allow it to sell cannabis extracts, topicals and edibles from its EU-GMP certified facility in Mississauga, Ontario. Sales of TerrAscend's new product formats will begin in December, pending Health Canada authorization. The company submitted 15 SKUs to Health Canada, including edibles, vape pens, and cartridges, to be authorized for launch this year. In addition, the company plans on submitting an expanded set of SKUs in the coming months.

"The addition of cannabis derivatives to our product line enables TerrAscend to better meet the needs of patients and customers, who demand safe, standardized products," said Michael Nashat, TerrAscend's CEO. "This approval also paves the way to bring our US brands and formulations to the Canadian market."

1933 Industries Inc. (CSE: TGIF) (OTCQX: TGIFF), reported on the Company's most successful brand launch to date.
Following a 30-day exclusive campaign with one of Nevada's largest dispensary retailers, luxury brand Blonde™ Cannabis made its mark in the state by selling out of every product during its debut. While the Blonde™ brand originated in Los Angeles, California, Nevada was selected for its launch in partnership with 1933 Industries' subsidiary, Alternative Medicine Association (AMA).     
"Blonde™ has taken Las Vegas by storm and we could not be more excited about this relationship", remarked Ms. Ester Vigil, President of 1933 Industries. "The positive feedback from consumers has been overwhelming. Blonde™ has been developed as a premium lifestyle product, connecting with both new and discerning, quality-savvy consumers looking for remarkable experiences." Blonde™ cannabis flower, pre-rolls, live resin vape pens and cartridges will be available for order as of today via licensed dispensaries.
The partnership with Blonde™ will continue in California, once the Company completes the renovation of the Green Spectrum facility and sets up its own extraction equipment (news release dated August 15, 2019). "The team behind Blonde™ are adept marketers and branders and will be lending their expertise as we build a house of brands in Nevada, California and in other legal states across the US", added Ms. Vigil. "We continue to attract top name brands to our portfolio due to our reputation for producing quality products that comply with the strictest regulations in the country."
"The buzz about Blonde™ has met and surpassed our expectations. We knew that launching a cannabis brand in a crowded marketplace would require key differentiators based not only on quality cannabis and sophisticated branding but also on a healthy lifestyle and culture that respects the plant. We have an opportunity here to inspire, educate and combat the stigma around cannabis. We are excited to launch in California next month and to continue to collaborate with 1933 Industries as we build our brand," said Mr. Tim Gavin, Co-Founder of Blonde™.
EnWave Corporation (TSX-V:ENW) (OTC: NWVCF) reported today that EnWave and Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) have signed an exclusive, royalty-bearing commercial license agreement with sub-licensing rights to use the Company’s proprietary Radiant Energy Vacuum (“REV™”) dehydration technology for the drying of cannabis in Australia. 

Aurora will hold an exclusive master license for the drying of cannabis using REV™ in Australia and will work closely with EnWave to pursue sub-licensing opportunities. If certain minimum commercialization requirements are met, Aurora will receive an undisclosed share of royalties derived from any cannabis product dried with REV™ technology by sub-licensees in Australia.

Concurrently with the signing of the Agreement, EnWave and Aurora have signed a royalty-bearing sublicense with Cann Group Limited (ASX: CAN), Australia’s first Medical Cannabis Cultivation Licensee.  The Sublicense grants Cann Group the right to use EnWave’s REVTM technology to dry cannabis in Australia. Pursuant to the Sublicense, Cann Group has signed an equipment purchase agreement to obtain a 10kW REV™ machine to initiate commercial production.

The Sublicense is the first sublicense granted by Aurora and EnWave and the fifth royalty-bearing commercial license agreement signed by EnWave to dry cannabis using its proprietary dehydration technology.

One World Pharma Inc. (OTC: OWPC) announced that it has entered into an exclusive, multi-year agreement with the WALA POPAYAN Co-operative, a highly skilled agrarian community in the Colombian Andes to collaborate in the cultivation and refinement of hemp-derived ingredients.

The agreement creates a partnership in which OWP blends the ancestral techniques of the Nasa people with modern technology, registered plant genetics and international standard operating procedures. The collaboration creates a true partnership that is expected to maximize the opportunity to grow in one of the most ideal climates for agriculture in the world. It allows for cultivation of hemp on the lands owned by the indigenous community.
OWP will supply the co-op with registered genetics in the form of seeds or plantlets to grow hemp and non-psychoactive cannabis. Under this agreement, OWP will advise the co-op on best practices in cultivation, harvesting and processing of the raw material. The agreement also provides for OWP to purchase the raw biomass produced under this agreement upon meeting quality control standards and lab testing. One World Pharma intends to then refine the biomass at its state-of-the-art facility for export. The hemp-derived ingredients are expected to be used in Consumer Packaged Goods (CPG) and Over The Counter (OTC) products being manufactured worldwide.

“One World Pharma has been extraordinary to our people and the opportunity to partner with such a visionary company will be outstanding,” stated Ariel Huetio Prieto, the founder and the legal representative of the co-op. “The technology and cultivation methods that One World Pharma brings are phenomenal. More than anything, we are working together as partners to offer a better life for our people, and for all of Colombia.”

“It is our mission to partner with the local indigenous communities and small farmers to produce high quality hemp ingredients for international sale. We expect this partnership will provide the indigenous community with the ability to participate in the global supply chain. Our process is a holistic approach that is expected to create a thriving local economy while generating significant revenue for our shareholders,” stated Craig Ellins, CEO of One World Pharma.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411

  


Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory






No comments: